Clinical implication of CD200 in chronic lymphoproliferative disorders

Level of expression of CD20 in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma

CD38 gene polymorphisms and susceptibility to B-cell lymphocytic leukemia

Expression of fibromodulin gene as a tumor associated antigen in B-cell chronic lymphocytic leukemia

Chemokines and chemokine receptors in haematological disorders

Telomerase activity in lymphoma

Molecular detection of 13q deletion in chronic lymphocytic leukemia

Targeted therapy for hematological malignancies

MDR-1 Polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia

The role of cyclin dependent kinase inhibitor p27 in chronic lymphocytic leukemia